NCT00654940

A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients

Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Effect Of Pregabalin In Post-Traumatic Neuropathic Pain Patients

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess whether a cross-over type study design in post-traumatic neuropathic patients can be used to assess the activity of potential analgesic agents

Detailed description

Methodology study to evaluate a cross-over study design in post-traumatic neuropathic pain patients.

Conditions

• Nerve Pain

Interventions

Type	Name	Description
DRUG	Pregabalin (Lyrica)	Oral, 75mg or 150mg capsules, BID
DRUG	Placebo	Oral, matched capsules, BID

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-02-01
• Completion: 2009-02-01
• First posted: 2008-04-09
• Last updated: 2021-02-09
• Results posted: 2010-02-24

Locations

5 sites across 2 countries: Canada, Sweden